Article info
PDFEpidemiology
Original article
High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine
- Correspondence to Dr Chris JLM Meijer, VUmc Cancer Centre Amsterdam, De Boelelaan, Amsterdam 1118, The Netherlands; cjlm.meijer{at}vumc.nl
Citation
High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine
Publication history
- Received January 18, 2017
- Revised July 21, 2017
- Accepted August 8, 2017
- First published October 11, 2017.
Online issue publication
May 18, 2018
Article Versions
- Previous version (18 May 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/